HOLLENCREST CAPITAL MANAGEMENT – Eli Lilly and Company Transaction History
HOLLENCREST CAPITAL MANAGEMENT portfolio value:
$338,000
portfolio value
HOLLENCREST CAPITAL MANAGEMENT quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +11.90% | 111 shares | 36K | $323.35 | 1.04K |
| Q2 2022 | share | Increase | +8.11% | 70 shares | 55K | $324.23 | 933 |
| Q1 2022 | share | Increase | +2.37% | 20 shares | 14K | $286.37 | 863 |
| Q4 2021 | share | Increase | 0.00% | 843 shares | 233K | $277.25 | 843 |
| Q2 2021 | share | Decrease | -100.00% | -1.64K shares | -308K | $228.04 | 0 |
| Q1 2021 | share | Decrease | -1.55% | -26 shares | 25K | $184.81 | 1.64K |
| Q4 2020 | share | 0.00% | 0 shares | 35K | $166.32 | 1.67K | |
| Q3 2020 | share | Decrease | -0.59% | -10 shares | -29K | $145.05 | 1.67K |
| Q2 2020 | share | Increase | 0.00% | 1.68K shares | 277K | $160.1 | 1.68K |
| Q2 2019 | share | Decrease | -100.00% | -6.05K shares | -785K | $105.74 | 0 |
| Q1 2019 | share | 0.00% | 0 shares | 85K | $123.17 | 6.05K | |
| Q4 2018 | share | 0.00% | 0 shares | -85K | $109.26 | 6.05K | |
| Q3 2018 | share | 0.00% | 0 shares | 269K | $100.8 | 6.05K | |
| Q2 2018 | share | 0.00% | 0 shares | 48K | $79.72 | 6.05K | |
| Q1 2018 | share | 0.00% | 0 shares | -43K | $71.78 | 6.05K | |
| Q4 2017 | share | Increase | +57.13% | 2.2K shares | 182K | $77.79 | 6.05K |
| Q3 2017 | share | Increase | 0.00% | 3.85K shares | 329K | $78.29 | 3.85K |
| Q4 2016 | share | Decrease | -100.00% | -2.76K shares | -222K | $66.02 | 0 |
| Q3 2016 | share | Decrease | -56.88% | -3.64K shares | -283K | $71.57 | 2.76K |
| Q2 2016 | share | Decrease | -1.34% | -87 shares | 37K | $69.79 | 6.41K |
| Q1 2016 | share | Decrease | -6.93% | -484 shares | -121K | $63.39 | 6.50K |